Covid: Welsh volunteers join booster vaccines trial in Wrexham
Published
It will provide data on the immune response to a third dose ahead of a potential rollout.
Full ArticlePublished
It will provide data on the immune response to a third dose ahead of a potential rollout.
Full ArticleNovavax, Inc. (NASDAQ:NVAX) said its COVID-19 vaccine was 90% effective in late-stage trials and was also tested in combination..